ANZAC: A NEOADJUVANT BIOMARKER STUDY EXPLORING THE ANTI-TUMOUR ACTIVITY OF THE ADDITION OF ZOLEDRONIC ACID TO CHEMOTHERAPY IN BREAST CANCERM. C. Winter,S. S. Cross,C. E. Ingram, I. J. Jolley,I. Holen,M. Q. Hatton,J. M. Horsman,R. ColemanANNALS OF ONCOLOGY(2009)引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要